NORTHWEST BIOTHERAPEUTICS INC Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 1.53 million shares for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2018-11-16
- NORTHWEST BIOTHERAPEUTICS INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-09-30 was 1.53M shares.
- NORTHWEST BIOTHERAPEUTICS INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-09-30 was 0.00 shares.
- NORTHWEST BIOTHERAPEUTICS INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-09-30 was 12.37M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month |
|---|---|---|
| 2018-09-30 | 1.53M shares 10-Q · filed 2018-11-16 | 0.00 shares 10-Q · filed 2018-11-16 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2018-11-16 | 0.00 shares 10-Q · filed 2018-11-16 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-10 | 0.00 shares 10-Q · filed 2016-11-10 |
| 2015-09-30 | 12.37M shares 10-Q · filed 2016-11-10 | 0.00 shares 10-Q · filed 2016-11-10 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-09 | 0.00 shares 10-Q · filed 2015-11-09 |